You’ve done everything right – the diet, the training, the lifestyle. But the fat around your midsection won’t move, your metabolism feels stuck, and your sharpness isn’t what it used to be. Tesamorelin is built for exactly this picture – and it’s the most clinically validated peptide in its class.
Protocols start at $250/month after a $599 Foundational Assessment. See full pricing
Tesamorelin is best suited for men and women over 35 who are dealing with stubborn visceral fat, early metabolic dysfunction, or early cognitive concerns that have already been medically evaluated – and who are ready for the most advanced peptide protocol available.
You may be a strong candidate if you:
Tesamorelin can be combined with BHRT depending on your full clinical picture. Our provider team will evaluate your labs, history, and goals before any protocol is built – nothing is prescribed without the complete picture.
Our Foundational Assessment is where it starts. It gives us – and you – everything we need.
There’s a specific type of fat that sits deep in the abdomen – surrounding your internal organs, driving inflammation, and quietly contributing to insulin resistance, cardiovascular risk, and metabolic dysfunction.1 Modest weight loss actually tends to shrink visceral fat preferentially, but it can be hard to reach and hold that loss. You can be lean everywhere else2 and still carry it.
That fat has a name: visceral adipose tissue. And Tesamorelin is the only peptide carrying an FDA approval specifically for reducing it — an approval granted for adults with HIV-associated lipodystrophy.34
Tesamorelin is a GHRH analog – it prompts your pituitary to release more of your own growth hormone, which declines steadily with age in adults. In clinical trials, this reduced visceral fat without significantly reducing the fat under the skin.56 The result isn’t just a change in how you look. It’s a meaningful shift in your metabolic health from the inside out.
This is the most advanced growth hormone optimization protocol offered at YoungerMeMD – and it’s built for patients who want more than maintenance.
Tesamorelin is administered five out of seven nights via subcutaneous injection. Most patients begin noticing meaningful changes within 6-12 weeks. Here’s what patients commonly report.
Visceral fat is metabolically stubborn by nature. In placebo-controlled trials in adults with HIV-associated abdominal fat, tesamorelin reduced visceral adipose tissue by about 15% relative to placebo over 26 weeks, and the reduction was maintained through 52 weeks with continued use. A 12-month trial in abdominally obese adults without HIV who had reduced growth hormone secretion also found a significant reduction.67
In a 20-week randomized trial published in Archives of Neurology (now JAMA Neurology), tesamorelin improved executive function in older adults with and without mild cognitive impairment, with a non-significant trend for verbal memory.9 For patients noticing early cognitive changes, this is one of the most compelling aspects of the protocol.
Every Tesamorelin prescription at YoungerMeMD is sourced exclusively from fully vetted, state-licensed 503A compounding pharmacies. Our peptides are never labeled “for research purposes.” They are compounded for prescription clinical use only – dispensed under physician supervision, prepared to strict standards for sterility, potency, and quality control.
Your metabolic health deserves pharmaceutical-grade precision. That is the only standard we use.
Tesamorelin was generally well tolerated in clinical trials. The most common side effects were joint pain, injection-site redness or itching, pain in the arms or legs, swelling from fluid retention, and muscle aches. It can also raise blood sugar, so glucose should be checked before and during treatment.13
Tesamorelin must not be used in people with active cancer, and any past cancer should be inactive with treatment complete before starting. It is also not used in people with pituitary or hypothalamic disorders (for example after pituitary surgery or head irradiation), and it should not be used during pregnancy or breastfeeding.13 Always inform your provider about all current medications, supplements, and existing health conditions before starting any protocol.
Consistent sleep, regular physical activity, stress management, and balanced nutrition support your treatment – deep sleep and body fat in particular are strong influences on natural growth hormone secretion.14
The most clinically validated visceral fat reduction and metabolic optimization protocol available – physician-supervised and built around your biology.
$599
A complete assessment of:
This establishes which Tesamorelin protocol is right for your picture and determines whether you begin at the low or high dose based on your clinical presentation.
$279/month
Your foundational membership provides continuous support and medical oversight.
Your Membership Includes:
We start every patient at the low dose and assess response before making any adjustments. Most patients achieve their goals at the low dose – escalation is guided by your biology, not a default.
Low Dose Protocol – $250/month
The starting protocol for all Tesamorelin patients. Administered five out of seven nights via subcutaneous injection. For patients who respond well at this level, this remains the ongoing protocol.
High Dose Protocol – $350/month
For patients whose results plateau or who don’t achieve satisfactory progress at the low dose. Administered five out of seven nights. Escalation is always provider-directed based on clinical response monitoring.
Either protocol is deemed an ongoing treatment. Your provider team monitors response and determines the appropriate dose level based on your labs, symptoms, and body composition changes over time.
Yes – and that matters. Tesamorelin is the only GHRH analog with FDA approval specifically for visceral fat reduction — granted for adults with HIV-associated lipodystrophy — giving it one of the most well-documented clinical safety profiles among all peptides available today.63 At YoungerMeMD, it is used off-label for adult metabolic and longevity optimization under the direct supervision of Dr. Varano and his provider team.
Tesamorelin is administered via subcutaneous injection – a small, fine-needle injection given at home five out of seven nights. Our care team provides full training and is available for support as you get started.
The published trials of tesamorelin used daily dosing. Our five-out-of-seven schedule is a clinical choice intended to avoid continuous stimulation; it has not yet been compared with daily dosing in published studies.4
We start every patient on the low dose protocol and monitor response over the first several weeks. For patients who respond well at the lower dose, there is no need to escalate. For patients who don’t achieve satisfactory results at the lower dose, we move to the high dose protocol. This approach minimizes unnecessary exposure and lets your biology guide the escalation decision rather than starting everyone at the ceiling.
Yes. A 20-week randomized trial published in Archives of Neurology (now JAMA Neurology) found improved executive function in older adults on tesamorelin, with a trend toward better verbal memory – making it one of the few peptides9 with published cognitive outcome data. For patients with early cognitive concerns, this is a meaningful part of the protocol.
Absolutely. Tesamorelin fits naturally within a broader optimization protocol and can be incorporated alongside BHRT or other peptide programs depending on your goals and where you are in your health journey. Every protocol is built individually by our provider team – nothing is stacked without clinical justification.
Tesamorelin is offered through YoungerMeMD’s membership-based model, which operates outside of traditional insurance. Your membership includes physician oversight, ongoing protocol management, and the kind of personalized attention that insurance-based care isn’t designed to provide.
Tesamorelin isn’t a starting point. It’s where patients who are serious about metabolic health, body composition, and cognitive longevity arrive when they’re ready to go further than anything else has taken them.
It starts with a conversation and the right labs. From there, our provider team builds a protocol around your specific picture – not a template, not a guess.
Visceral fat and metabolic dysfunction rarely exist in isolation. These protocols address the systemic layers that determine how completely and how durably Tesamorelin's results take hold — and what becomes possible once the metabolic environment shifts.
Sex hormones shape body composition: in a controlled study of men, estrogen deficiency mainly increased body fat, while testosterone deficiency reduced lean mass and strength.15 Tesamorelin addresses the growth hormone layer, while hormone optimization addresses the sex hormone layer that shapes the metabolic environment it works in.
Best for: patients over 40 whose visceral fat and metabolic decline have a clear hormonal component alongside GH deficiency
Learn about Hormone HealthExcess visceral fat goes along with lower natural growth hormone production and low-grade inflammation. Thymosin Alpha-1 is an immune-modulating peptide; it has not yet been studied as a treatment for visceral fat.148
Best for: patients with elevated CRP, chronic inflammation, or autoimmune history complicating visceral fat reduction
Learn about DefendMeTesamorelin has published trial data showing improved executive function in older adults. Semax works through a different pathway: in rat studies it increased BDNF, a growth factor involved in neuroplasticity. The combination has not yet been studied in people.916
Best for: patients seeking both visceral fat reduction and meaningful cognitive restoration as primary goals
Learn about CognitiveMeGut health and inflammation are being studied as possible contributors to insulin resistance and visceral fat. BPC-157 and KPV have mainly been studied in animal and laboratory models, and they have not yet been shown to improve tesamorelin’s results in people.
Best for: patients with GI symptoms, metabolic dysfunction, or inflammatory markers suggesting a gut-driven metabolic component
Learn about Gut RestorationFill up the form below to get started
Provocation agent administered prior to timed urine collection (<6hr). Reveals toxic metal burden that can block hormone and peptide response.
Identifies gluten sensitivity, intestinal permeability (leaky gut), and wheat-related immune reactivity – distinct from standard celiac testing.
DNA Based stool test detecting pathogens, bacterial imbalances, parasites, and digestive markers – a comprehensive gut microbiome assessment.
Non-invasive carotid artery ultrasound measuring arterial wall thickness – a direct look at your cardiovascular age.
Cardio Res-Q cardiac risk panel – inflammation markers and cardiovascular biomarkers beyond standard labs.
Evaluates intracellular vitamin, mineral, and antioxidant status – foundational to optimizing cellular health and peptide efficacy.
Full Sex hormone, thyroid and adrenal picture. Identifies imbalances that affect energy, recovery, cognition, and peptide response.
Advanced testing for immune reactions to wheat, gluten, and intestinal permeability.
What It Evaluates
Heavy metals like mercury, lead, cadmium, arsenic, and aluminum can cause:
Conditions We Identify
